足白癬治療市場：タイプ別、適応症別、投与経路別、販売チャネル別-2025-2030年世界予測

足白癬治療市場は、2023年に14億9,000万米ドルと評価され、2024年には15億7,000万米ドルに達すると予測され、CAGR 6.20％で成長し、2030年には22億8,000万米ドルに達すると予測されています。

一般に水虫として知られる足白癬は、足の皮膚を侵す広範な真菌感染症です。その治療市場には、症状の緩和、再発防止、感染拡大の抑制に必要な、外用剤と経口剤の両方の抗真菌製品があります。治療用途は市販薬、処方薬、自然療法に及び、最終用途は薬局、病院、専門クリニックなどで、アスリートから免疫力の低下した患者まで多様な患者層に対応しています。市場参入企業の成長は、真菌感染症に対する意識の高まり、スポーツジムやスポーツ参加者の増加、感染症にかかりやすい高齢者人口の増加といった要因に加え、より優れた有効性と副作用の軽減を提供する抗真菌薬の進歩が後押ししています。長時間作用型製剤や速効型製剤のような新規治療法の開拓、アンメット・メディカル・ニーズの高い新興国市場への浸透、遠隔診断と治療アドバイスのための遠隔医療の統合などがチャンスです。しかし、厳しい規制当局の承認、抗真菌薬に伴う副作用の可能性、代替療法や家庭療法との競合などの課題も残っています。また、原材料費の変動や長期使用による薬剤耐性の可能性からも限界が生じる。技術革新は、患者の服薬アドヒアランスを高める製剤の改良、バイオテクノロジーを活用した先進的な抗真菌剤の開発、感染耐性におけるマイクロバイオームの役割の調査などに重点を置く必要があります。市場は消費者の健康動向と技術の進歩が相互に影響し合うダイナミックな市場であり、規制状況や患者の医療嗜好の継続的なモニタリングが求められます。企業は、皮膚科医や医療機関とのパートナーシップを活用することで、信頼性と市場浸透を強化し、最終的には国際的な健康基準の遵守を確保しながら、ターゲットとなる消費者の進化するニーズに応えることができます。

市場力学：急速に進化する足白癬治療市場の主要市場インサイトを公開

足白癬治療市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 人口における足白癬の著しい蔓延
  • 皮膚疾患に対する意識の高まり
  • 各国におけるOTC皮膚科製品の入手の容易さ
• 市場抑制要因
  • 製品回収に関連する大きな問題
• 市場機会
  • 足白癬に対する新たな治療オプションの出現
  • 遠隔医療とバーチャルヘルスケアの動向の高まり
• 市場の課題
  • 資本集約的で時間のかかる承認プロセス

ポーターの5つの力：足白癬治療市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：足白癬治療市場における外部からの影響の把握

外部マクロ環境要因は、足白癬治療市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析足白癬治療市場における競合情勢の把握

足白癬治療市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的な意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス足白癬治療市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、足白癬治療市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨足白癬治療市場における成功への道筋を描く

足白癬治療市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 人口における足白癬の有病率の高さ
    • 皮膚疾患に関する意識の高まり
    • 各国の経済圏で市販の皮膚科製品が容易に入手可能
  • 抑制要因
    • 製品リコールに関連する重大な問題
  • 機会
    • 足白癬の新たな治療法の出現
    • 遠隔医療とバーチャルヘルスケアの台頭
  • 課題
    • 資本集約型で時間のかかる承認プロセス
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 足白癬治療市場：タイプ別

• 抗真菌薬
• 乾燥剤

第7章 足白癬治療市場適応症の種類別

• 急性潰瘍性足白癬
• 慢性角質増殖性足白癬
• 慢性間擦性足白癬
• 水疱性足白癬

第8章 足白癬治療市場：投与経路別

• オーラル
• 話題
  • クリーム＆ローション
  • ゲル
  • 粉
  • スプレー

第9章 足白癬治療市場：販売チャネル別

• オフライン
  • 病院・クリニック
  • 薬局
• オンライン

第10章 南北アメリカの足白癬治療市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の足白癬治療市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの足白癬治療市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• Aetna Inc
• Alva-Amco Pharmacal Companies, Inc
• Amneal Pharmaceuticals Inc.
• Aurobindo Pharma Limited
• Bausch Health Companies Inc.
• Bayer AG
• Blueberry Therapeutics Ltd.
• Cipla Ltd.
• Creative Biolabs
• Dr. Reddy's Laboratories Ltd.
• Enzon Pharmaceuticals, Inc.
• GlaxoSmithKline PLC
• Glenmark Pharmaceuticals Limited
• Merck & Co., Inc.
• Mylan N.V.
• Novartis AG
• Perrigo Company PLC
• ProFoot, Inc.
• Sebela Pharmaceuticals Holdings Inc.
• Steris Healthcare PVT Ltd
• Sun Pharmaceutical Industries Ltd.
• Taisho Pharmaceutical Co., Ltd.
• Vibcare Pharma Pvt. Ltd.

LIST OF FIGURES

• FIGURE 1. TINEA PEDIS TREATMENT MARKET RESEARCH PROCESS
• FIGURE 2. TINEA PEDIS TREATMENT MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY INDICATION TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY INDICATION TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS TINEA PEDIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS TINEA PEDIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES TINEA PEDIS TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES TINEA PEDIS TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC TINEA PEDIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC TINEA PEDIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA TINEA PEDIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA TINEA PEDIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. TINEA PEDIS TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. TINEA PEDIS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. TINEA PEDIS TREATMENT MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. TINEA PEDIS TREATMENT MARKET DYNAMICS
• TABLE 7. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY ANTIFUNGALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY DRYING AGENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY ACUTE ULCERATIVE TINEA PEDIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY CHRONIC HYPERKERATOTIC TINEA PEDIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY CHRONIC INTERTRIGINOUS TINEA PEDIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY VESICULOBULLOUS TINEA PEDIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY CREAM & LOTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY GEL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY SPRAY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS TINEA PEDIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS TINEA PEDIS TREATMENT MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS TINEA PEDIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS TINEA PEDIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 35. AMERICAS TINEA PEDIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 36. ARGENTINA TINEA PEDIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 37. ARGENTINA TINEA PEDIS TREATMENT MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
• TABLE 38. ARGENTINA TINEA PEDIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 39. ARGENTINA TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
• TABLE 40. ARGENTINA TINEA PEDIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 41. ARGENTINA TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 42. BRAZIL TINEA PEDIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 43. BRAZIL TINEA PEDIS TREATMENT MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
• TABLE 44. BRAZIL TINEA PEDIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 45. BRAZIL TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
• TABLE 46. BRAZIL TINEA PEDIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 47. BRAZIL TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 48. CANADA TINEA PEDIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 49. CANADA TINEA PEDIS TREATMENT MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
• TABLE 50. CANADA TINEA PEDIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 51. CANADA TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
• TABLE 52. CANADA TINEA PEDIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 53. CANADA TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 54. MEXICO TINEA PEDIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 55. MEXICO TINEA PEDIS TREATMENT MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
• TABLE 56. MEXICO TINEA PEDIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 57. MEXICO TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
• TABLE 58. MEXICO TINEA PEDIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 59. MEXICO TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 60. UNITED STATES TINEA PEDIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 61. UNITED STATES TINEA PEDIS TREATMENT MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
• TABLE 62. UNITED STATES TINEA PEDIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 63. UNITED STATES TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
• TABLE 64. UNITED STATES TINEA PEDIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 65. UNITED STATES TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 66. UNITED STATES TINEA PEDIS TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 67. ASIA-PACIFIC TINEA PEDIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 68. ASIA-PACIFIC TINEA PEDIS TREATMENT MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
• TABLE 69. ASIA-PACIFIC TINEA PEDIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 70. ASIA-PACIFIC TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
• TABLE 71. ASIA-PACIFIC TINEA PEDIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 72. ASIA-PACIFIC TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 73. ASIA-PACIFIC TINEA PEDIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 74. AUSTRALIA TINEA PEDIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 75. AUSTRALIA TINEA PEDIS TREATMENT MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
• TABLE 76. AUSTRALIA TINEA PEDIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 77. AUSTRALIA TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
• TABLE 78. AUSTRALIA TINEA PEDIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 79. AUSTRALIA TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 80. CHINA TINEA PEDIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 81. CHINA TINEA PEDIS TREATMENT MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
• TABLE 82. CHINA TINEA PEDIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 83. CHINA TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
• TABLE 84. CHINA TINEA PEDIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 85. CHINA TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 86. INDIA TINEA PEDIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 87. INDIA TINEA PEDIS TREATMENT MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
• TABLE 88. INDIA TINEA PEDIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 89. INDIA TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
• TABLE 90. INDIA TINEA PEDIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 91. INDIA TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 92. INDONESIA TINEA PEDIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 93. INDONESIA TINEA PEDIS TREATMENT MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
• TABLE 94. INDONESIA TINEA PEDIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 95. INDONESIA TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
• TABLE 96. INDONESIA TINEA PEDIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 97. INDONESIA TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 98. JAPAN TINEA PEDIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 99. JAPAN TINEA PEDIS TREATMENT MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
• TABLE 100. JAPAN TINEA PEDIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 101. JAPAN TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
• TABLE 102. JAPAN TINEA PEDIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 103. JAPAN TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 104. MALAYSIA TINEA PEDIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 105. MALAYSIA TINEA PEDIS TREATMENT MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
• TABLE 106. MALAYSIA TINEA PEDIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 107. MALAYSIA TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
• TABLE 108. MALAYSIA TINEA PEDIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 109. MALAYSIA TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 110. PHILIPPINES TINEA PEDIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 111. PHILIPPINES TINEA PEDIS TREATMENT MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
• TABLE 112. PHILIPPINES TINEA PEDIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 113. PHILIPPINES TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
• TABLE 114. PHILIPPINES TINEA PEDIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 115. PHILIPPINES TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 116. SINGAPORE TINEA PEDIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 117. SINGAPORE TINEA PEDIS TREATMENT MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
• TABLE 118. SINGAPORE TINEA PEDIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 119. SINGAPORE TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
• TABLE 120. SINGAPORE TINEA PEDIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 121. SINGAPORE TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 122. SOUTH KOREA TINEA PEDIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 123. SOUTH KOREA TINEA PEDIS TREATMENT MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
• TABLE 124. SOUTH KOREA TINEA PEDIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH KOREA TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH KOREA TINEA PEDIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH KOREA TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 128. TAIWAN TINEA PEDIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 129. TAIWAN TINEA PEDIS TREATMENT MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
• TABLE 130. TAIWAN TINEA PEDIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 131. TAIWAN TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
• TABLE 132. TAIWAN TINEA PEDIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 133. TAIWAN TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 134. THAILAND TINEA PEDIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 135. THAILAND TINEA PEDIS TREATMENT MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
• TABLE 136. THAILAND TINEA PEDIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 137. THAILAND TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
• TABLE 138. THAILAND TINEA PEDIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 139. THAILAND TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 140. VIETNAM TINEA PEDIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 141. VIETNAM TINEA PEDIS TREATMENT MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
• TABLE 142. VIETNAM TINEA PEDIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 143. VIETNAM TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
• TABLE 144. VIETNAM TINEA PEDIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 145. VIETNAM TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 146. EUROPE, MIDDLE EAST & AFRICA TINEA PEDIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 147. EUROPE, MIDDLE EAST & AFRICA TINEA PEDIS TREATMENT MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
• TABLE 148. EUROPE, MIDDLE EAST & AFRICA TINEA PEDIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 149. EUROPE, MIDDLE EAST & AFRICA TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
• TABLE 150. EUROPE, MIDDLE EAST & AFRICA TINEA PEDIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 151. EUROPE, MIDDLE EAST & AFRICA TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 152. EUROPE, MIDDLE EAST & AFRICA TINEA PEDIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 153. DENMARK TINEA PEDIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 154. DENMARK TINEA PEDIS TREATMENT MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
• TABLE 155. DENMARK TINEA PEDIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 156. DENMARK TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
• TABLE 157. DENMARK TINEA PEDIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 158. DENMARK TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 159. EGYPT TINEA PEDIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 160. EGYPT TINEA PEDIS TREATMENT MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
• TABLE 161. EGYPT TINEA PEDIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 162. EGYPT TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
• TABLE 163. EGYPT TINEA PEDIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 164. EGYPT TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 165. FINLAND TINEA PEDIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 166. FINLAND TINEA PEDIS TREATMENT MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
• TABLE 167. FINLAND TINEA PEDIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 168. FINLAND TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
• TABLE 169. FINLAND TINEA PEDIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 170. FINLAND TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 171. FRANCE TINEA PEDIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 172. FRANCE TINEA PEDIS TREATMENT MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
• TABLE 173. FRANCE TINEA PEDIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 174. FRANCE TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
• TABLE 175. FRANCE TINEA PEDIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 176. FRANCE TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 177. GERMANY TINEA PEDIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 178. GERMANY TINEA PEDIS TREATMENT MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
• TABLE 179. GERMANY TINEA PEDIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 180. GERMANY TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
• TABLE 181. GERMANY TINEA PEDIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 182. GERMANY TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 183. ISRAEL TINEA PEDIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 184. ISRAEL TINEA PEDIS TREATMENT MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
• TABLE 185. ISRAEL TINEA PEDIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 186. ISRAEL TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
• TABLE 187. ISRAEL TINEA PEDIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 188. ISRAEL TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 189. ITALY TINEA PEDIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 190. ITALY TINEA PEDIS TREATMENT MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
• TABLE 191. ITALY TINEA PEDIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 192. ITALY TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
• TABLE 193. ITALY TINEA PEDIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 194. ITALY TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 195. NETHERLANDS TINEA PEDIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 196. NETHERLANDS TINEA PEDIS TREATMENT MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
• TABLE 197. NETHERLANDS TINEA PEDIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 198. NETHERLANDS TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
• TABLE 199. NETHERLANDS TINEA PEDIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 200. NETHERLANDS TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 201. NIGERIA TINEA PEDIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 202. NIGERIA TINEA PEDIS TREATMENT MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
• TABLE 203. NIGERIA TINEA PEDIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 204. NIGERIA TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
• TABLE 205. NIGERIA TINEA PEDIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 206. NIGERIA TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 207. NORWAY TINEA PEDIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 208. NORWAY TINEA PEDIS TREATMENT MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
• TABLE 209. NORWAY TINEA PEDIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 210. NORWAY TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
• TABLE 211. NORWAY TINEA PEDIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 212. NORWAY TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 213. POLAND TINEA PEDIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 214. POLAND TINEA PEDIS TREATMENT MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
• TABLE 215. POLAND TINEA PEDIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 216. POLAND TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
• TABLE 217. POLAND TINEA PEDIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 218. POLAND TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 219. QATAR TINEA PEDIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 220. QATAR TINEA PEDIS TREATMENT MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
• TABLE 221. QATAR TINEA PEDIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 222. QATAR TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
• TABLE 223. QATAR TINEA PEDIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 224. QATAR TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 225. RUSSIA TINEA PEDIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 226. RUSSIA TINEA PEDIS TREATMENT MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
• TABLE 227. RUSSIA TINEA PEDIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 228. RUSSIA TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
• TABLE 229. RUSSIA TINEA PEDIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 230. RUSSIA TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 231. SAUDI ARABIA TINEA PEDIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 232. SAUDI ARABIA TINEA PEDIS TREATMENT MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
• TABLE 233. SAUDI ARABIA TINEA PEDIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 234. SAUDI ARABIA TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
• TABLE 235. SAUDI ARABIA TINEA PEDIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 236. SAUDI ARABIA TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 237. SOUTH AFRICA TINEA PEDIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 238. SOUTH AFRICA TINEA PEDIS TREATMENT MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
• TABLE 239. SOUTH AFRICA TINEA PEDIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 240. SOUTH AFRICA TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
• TABLE 241. SOUTH AFRICA TINEA PEDIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 242. SOUTH AFRICA TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 243. SPAIN TINEA PEDIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 244. SPAIN TINEA PEDIS TREATMENT MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
• TABLE 245. SPAIN TINEA PEDIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 246. SPAIN TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
• TABLE 247. SPAIN TINEA PEDIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 248. SPAIN TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 249. SWEDEN TINEA PEDIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 250. SWEDEN TINEA PEDIS TREATMENT MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
• TABLE 251. SWEDEN TINEA PEDIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 252. SWEDEN TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
• TABLE 253. SWEDEN TINEA PEDIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 254. SWEDEN TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 255. SWITZERLAND TINEA PEDIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 256. SWITZERLAND TINEA PEDIS TREATMENT MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
• TABLE 257. SWITZERLAND TINEA PEDIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 258. SWITZERLAND TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
• TABLE 259. SWITZERLAND TINEA PEDIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 260. SWITZERLAND TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 261. TURKEY TINEA PEDIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 262. TURKEY TINEA PEDIS TREATMENT MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
• TABLE 263. TURKEY TINEA PEDIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 264. TURKEY TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
• TABLE 265. TURKEY TINEA PEDIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 266. TURKEY TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 267. UNITED ARAB EMIRATES TINEA PEDIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 268. UNITED ARAB EMIRATES TINEA PEDIS TREATMENT MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
• TABLE 269. UNITED ARAB EMIRATES TINEA PEDIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 270. UNITED ARAB EMIRATES TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
• TABLE 271. UNITED ARAB EMIRATES TINEA PEDIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 272. UNITED ARAB EMIRATES TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 273. UNITED KINGDOM TINEA PEDIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 274. UNITED KINGDOM TINEA PEDIS TREATMENT MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
• TABLE 275. UNITED KINGDOM TINEA PEDIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 276. UNITED KINGDOM TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
• TABLE 277. UNITED KINGDOM TINEA PEDIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 278. UNITED KINGDOM TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 279. TINEA PEDIS TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 280. TINEA PEDIS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

The Tinea Pedis Treatment Market was valued at USD 1.49 billion in 2023, expected to reach USD 1.57 billion in 2024, and is projected to grow at a CAGR of 6.20%, to USD 2.28 billion by 2030.

Tinea Pedis, commonly known as athlete's foot, is a widespread fungal infection affecting the skin on the feet. The market for its treatment encompasses a range of antifungal products, both topical and oral, necessary for relieving symptoms, preventing recurrence, and inhibiting the spread of infection. Applications span across over-the-counter products, prescription treatments, and natural remedies, with end-use segments including pharmacies, hospitals, and specialty clinics, addressing a diverse patient base from athletes to individuals with compromised immunity. Market growth is propelled by factors such as increasing awareness of fungal infections, the rise in gym and sports participation, and the growing geriatric population susceptible to infections, matched with advancements in antifungal medications that offer better efficacy and reduced side effects. Opportunities lie in the development of novel treatments like long-acting and rapid-onset formulas, penetration into emerging markets with high unmet medical needs, and integration of telemedicine for remote diagnosis and treatment advice. However, challenges persist due to stringent regulatory approvals, potential side effects associated with antifungal drugs, and competition from alternative and home remedies. Limitations also arise from fluctuating raw material costs and the potential for drug resistance with prolonged use. Innovation should focus on enhancing drug formulations for increased patient adherence, leveraging biotechnology for advanced antifungal agents, and investigating the microbiome's role in infection resistance. The market is dynamic, driven by the interplay of consumer health trends and technological advancements, demanding continuous monitoring of regulatory landscapes and patient health care preferences. Businesses can leverage partnerships with dermatologists and health care organizations to bolster credibility and market penetration, ultimately catering to the evolving needs of target consumers while ensuring compliance with international health standards.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Tinea Pedis Treatment Market

The Tinea Pedis Treatment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Significant prevalence of tinea pedis among population
  • Growing awareness about dermatological disorders
  • Easy availability of OTC dermatological products across economies
• Market Restraints
  • Considerable issues associated with product recall
• Market Opportunities
  • Emergence of new treatment options for tinea pedis
  • Rising trend of telemedicine and virtual healthcare
• Market Challenges
  • Capital intensive and time consuming approval process

Porter's Five Forces: A Strategic Tool for Navigating the Tinea Pedis Treatment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Tinea Pedis Treatment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Tinea Pedis Treatment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Tinea Pedis Treatment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Tinea Pedis Treatment Market

A detailed market share analysis in the Tinea Pedis Treatment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Tinea Pedis Treatment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Tinea Pedis Treatment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Tinea Pedis Treatment Market

A strategic analysis of the Tinea Pedis Treatment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Tinea Pedis Treatment Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Aetna Inc, Alva-Amco Pharmacal Companies, Inc, Amneal Pharmaceuticals Inc., Aurobindo Pharma Limited, Bausch Health Companies Inc., Bayer AG, Blueberry Therapeutics Ltd., Cipla Ltd., Creative Biolabs, Dr. Reddy's Laboratories Ltd., Enzon Pharmaceuticals, Inc., GlaxoSmithKline PLC, Glenmark Pharmaceuticals Limited, Merck & Co., Inc., Mylan N.V., Novartis AG, Perrigo Company PLC, ProFoot, Inc., Sebela Pharmaceuticals Holdings Inc., Steris Healthcare PVT Ltd, Sun Pharmaceutical Industries Ltd., Taisho Pharmaceutical Co., Ltd., and Vibcare Pharma Pvt. Ltd..

Market Segmentation & Coverage

This research report categorizes the Tinea Pedis Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Antifungals and Drying Agents.
• Based on Indication Type, market is studied across Acute Ulcerative Tinea Pedis, Chronic Hyperkeratotic Tinea Pedis, Chronic Intertriginous Tinea Pedis, and Vesiculobullous Tinea Pedis.
• Based on Route Of Administration, market is studied across Oral and Topical. The Topical is further studied across Cream & Lotion, Gel, Powder, and Spray.
• Based on Sales Channel, market is studied across Offline and Online. The Offline is further studied across Hospitals & Clinics and Pharmacies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Significant prevalence of tinea pedis among population
    • 5.1.1.2. Growing awareness about dermatological disorders
    • 5.1.1.3. Easy availability of OTC dermatological products across economies
  • 5.1.2. Restraints
    • 5.1.2.1. Considerable issues associated with product recall
  • 5.1.3. Opportunities
    • 5.1.3.1. Emergence of new treatment options for tinea pedis
    • 5.1.3.2. Rising trend of telemedicine and virtual healthcare
  • 5.1.4. Challenges
    • 5.1.4.1. Capital intensive and time consuming approval process
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Tinea Pedis Treatment Market, by Type

• 6.1. Introduction
• 6.2. Antifungals
• 6.3. Drying Agents

7. Tinea Pedis Treatment Market, by Indication Type

• 7.1. Introduction
• 7.2. Acute Ulcerative Tinea Pedis
• 7.3. Chronic Hyperkeratotic Tinea Pedis
• 7.4. Chronic Intertriginous Tinea Pedis
• 7.5. Vesiculobullous Tinea Pedis

8. Tinea Pedis Treatment Market, by Route Of Administration

• 8.1. Introduction
• 8.2. Oral
• 8.3. Topical
  • 8.3.1. Cream & Lotion
  • 8.3.2. Gel
  • 8.3.3. Powder
  • 8.3.4. Spray

9. Tinea Pedis Treatment Market, by Sales Channel

• 9.1. Introduction
• 9.2. Offline
  • 9.2.1. Hospitals & Clinics
  • 9.2.2. Pharmacies
• 9.3. Online

10. Americas Tinea Pedis Treatment Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Tinea Pedis Treatment Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Tinea Pedis Treatment Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Aetna Inc
• 3. Alva-Amco Pharmacal Companies, Inc
• 4. Amneal Pharmaceuticals Inc.
• 5. Aurobindo Pharma Limited
• 6. Bausch Health Companies Inc.
• 7. Bayer AG
• 8. Blueberry Therapeutics Ltd.
• 9. Cipla Ltd.
• 10. Creative Biolabs
• 11. Dr. Reddy's Laboratories Ltd.
• 12. Enzon Pharmaceuticals, Inc.
• 13. GlaxoSmithKline PLC
• 14. Glenmark Pharmaceuticals Limited
• 15. Merck & Co., Inc.
• 16. Mylan N.V.
• 17. Novartis AG
• 18. Perrigo Company PLC
• 19. ProFoot, Inc.
• 20. Sebela Pharmaceuticals Holdings Inc.
• 21. Steris Healthcare PVT Ltd
• 22. Sun Pharmaceutical Industries Ltd.
• 23. Taisho Pharmaceutical Co., Ltd.
• 24. Vibcare Pharma Pvt. Ltd.